328 results on '"Tang, Jinhai"'
Search Results
2. The relationship between prognosis and temporal muscle thickness in 102 patients with glioblastoma
3. Effect of adjuvant radiotherapy on overall survival and breast cancer-specific survival of patients with malignant phyllodes tumor of the breast in different age groups: a retrospective observational study based on SEER
4. PHF20 is a Novel Prognostic Biomarker and Correlated with Immune Status in Breast Cancer
5. RelB-activated GPX4 inhibits ferroptosis and confers tamoxifen resistance in breast cancer
6. CACA Guidelines for Holistic Integrative Management of Breast Cancer
7. Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
8. PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
9. Hybridized double-shell periodic mesoporous organosilica nanotheranostics for ultrasound imaging guided photothermal therapy
10. Heterogeneity of CTC contributes to the organotropism of breast cancer
11. Accuracy of Thoracic Ultrasonography for the Diagnosis of Pediatric Pneumonia: A Systematic Review and Meta-Analysis
12. HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and migration
13. Heterogeneity of BCSCs contributes to the metastatic organotropism of breast cancer
14. HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
15. The long noncoding RNA TINCR promotes breast cancer cell proliferation and migration by regulating OAS1
16. HJURP indicates poor prognosis of female breast cancer by promoting cell proliferation and migration
17. Systematic review and metanalysis of neutrophil to lymphocyte ratio and prognosis in patients with nasopharyngeal carcinoma
18. Advances in the relationship between temporal muscle thickness and prognosis of patients with glioblastoma: a narrative review
19. RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression
20. SOX9 interacts with FOXC1 to activate MYC and regulate CDK7 inhibitor sensitivity in triple-negative breast cancer
21. A simplified non-coplanar volumetric modulated arc therapy for the whole brain radiotherapy with hippocampus avoidance
22. Abstract P6-14-11: Exosome-mediated Circ-CRSP1 promotes tumor proliferation and metastasis through stabilizing ELAVL1 protein and suppresses anti-tumor immune response in regulating the progression of Triple-Negative Breast Cancer
23. Abstract P4-03-31: Lifestyle factors are associated with breast cancer risk in women biopsied for benign breast diseases in China: 10-year results of a multi-center, hospital-based, case-control study
24. Integrative analysis of the role of BOLA2B in human pan-cancer
25. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles
26. Sacituzumab govitecan in HR+HER2−metastatic breast cancer: the randomized phase 3 EVER-132-002 trial
27. Efficacy and toxicity of apatinib combined with or without chemotherapy for patients with advanced or metastatic chemotherapy-refractory gastric adenocarcinoma: A prospective clinical study
28. Identification of Key Biomarkers and Candidate Molecules in Non-Small-Cell Lung Cancer by Integrated Bioinformatics Analysis
29. Additional file 1 of Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial
30. Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
31. Malignant adenomyoepithelioma of the breast: cases report and literature review
32. Mediation role of work motivation and job satisfaction between work-related basic need satisfaction and work engagement among doctors in China: a cross-sectional study
33. Immunometabolism characteristics and a potential prognostic risk model associated with TP53 mutations in breast cancer
34. Roles and mechanisms of miR-195–5p in human solid cancers
35. SARS-CoV-2 in the pancreas and the impaired islet function in COVID-19 patients
36. Abstract P5-18-06: Proactive diarrhea management improved tolerability of pyrotinib in combination with trastuzumab and docetaxel in patients with HER2+ early or locally advanced breast cancer: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study
37. Abstract PD8-08: Pyrotinib in combination with trastuzumab and docetaxel as neoadjuvant treatment for HER2-positive early or locally advanced breast cancer (PHEDRA): A randomized, double-blind, multicenter, phase 3 study
38. Abstract P5-18-10: Mecapegfilgrastim for primary prophylaxis of neutropenia in 355 HER2+ breast cancer patients treated with neoadjuvant docetaxel in combination with trastuzumab and/or pyrotinib: Exploratory analysis from randomized, double-blind, phase 3 PHEDRA study
39. Single-Nucleotide Polymorphisms in LEP and LEPR Associated With Breast Cancer Risk: Results From a Multicenter Case–Control Study in Chinese Females
40. Predictors of Neoadjuvant Chemotherapy Response in Breast Cancer: A Review
41. miR-641 Inhibited Cell Proliferation and Induced Apoptosis by Targeting NUCKS1/PI3K/AKT Signaling Pathway in Breast Cancer
42. MGP promotes CD8+ T cell exhaustion by activating the NF-κB pathway leading to liver metastasis of colorectal cancer
43. MiR-424 regulates monocytic differentiation of human leukemia U937 cells by directly targeting CDX2
44. Nonmetastatic breast cancer patients subsequently developing second primary malignancy: A population‐based study
45. Integrated Bioinformatics and Experimental Approaches Identified the Role of NPPA in the Proliferation and the Malignant Behavior of Breast Cancer
46. Abnormal Coagulation Function of Patients With COVID-19 Is Significantly Related to Hypocalcemia and Severe Inflammation
47. Novel Long Noncoding RNA 005620 Induces Epirubicin Resistance in Triple-Negative Breast Cancer by Regulating ITGB1 Expression
48. Small extracellular vesicles deliver TGF‐β1 and promote adriamycin resistance in breast cancer cells
49. Abstract PS16-27: Small extracellular vesicle-mediated intercellular TGF-β1 transferring promotes adriamycin-resistant transmission in breast cancer cells
50. Integrative analyses of scRNA-seq and scATAC-seq reveal CXCL14 as a key regulator of lymph node metastasis in breast cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.